Expert makes case for patient-specific dosimetry

06/13/2013 | MolecularImaging.net

To improve patient diagnosis and therapy, there is a need to advance patient-specific dosimetry, said Hal Anger Lectureship & Award lecturer Michael G. Stabin, a researcher at Vanderbilt University School of Medicine, in a message at the SNMMI Annual Meeting. "We have a new generation of dose phantoms and selection of sophisticated [dose planning tools and] methods ... and it's time to incorporate dose calculations into clinical therapy planning ... Our understanding of radiobiology is undergoing profound change. We will be rewriting history soon," Stabin said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC